Pharmaceutical

Filter

Current filters:

None

Popular Filters

21 to 45 of 7041 results

Moshe Manor appointed president and chief executive of Protalix BioTherapeutics

Moshe Manor appointed president and chief executive of Protalix BioTherapeutics

29-09-2014

Israeli pharma company Protalix BioTherapeutics has appointed Moshe Manor as its new president and chief…

BoardroomIsraelPharmaceuticalPresident and chief executiveProtalix BioTherapeutics

ESMO 2014: Novartis’ Afinitor; and Janssen’s Zytiga

ESMO 2014: Novartis’ Afinitor; and Janssen’s Zytiga

28-09-2014

Swiss pharma major Novartis on Saturday presented final results on overall survival (OS) from a Phase…

AfinitorJanssenJohnson & JohnsonNovartisOncologyPharmaceuticalResearchSpainZytiga

US FDA approves Iluvien for diabetic macular edema

US FDA approves Iluvien for diabetic macular edema

28-09-2014

US ophthalmic drug specialist Alimera Sciences says that the US Food and Drug Administration has approved…

Alimera SciencesIluvienMedidurOphthalmicsPharmaceuticalpSividaRegulationTethadurUSA

Bayer’s Jadelle to be listed in New Zealand

Bayer’s Jadelle to be listed in New Zealand

26-09-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC has announced the approval of an agreement with…

BayerJadelleMarkets & MarketingNew ZealandPharmaceuticalPricingReproductiveWomen's Health

Japan’s non-Hodgkin lymphoma market to exceed $1 billion by 2020

Japan’s non-Hodgkin lymphoma market to exceed $1 billion by 2020

26-09-2014

The non-Hodgkin lymphoma (NHL) treatment market in the Asia-Pacific (APAC) countries of India, Australia,…

AdcetrisAustraliaChinaGazyvaroIndiaJapanMarkets & MarketingOncologyPharmaceuticalRocheTakeda Pharmaceutical

EFPIA affirms strengthened commitment of industry in China with successful Beijing visit

EFPIA affirms strengthened commitment of industry in China with successful Beijing visit

26-09-2014

Trade group the European Federation of Pharmaceutical Industries and Associations (EFPIA) claims that…

ChinaEuropeHealthcareMarkets & MarketingPharmaceuticalPolitics

1 in 10 antibiotic prescriptions fail, according to new research

1 in 10 antibiotic prescriptions fail, according to new research

26-09-2014

One in 10 antibiotic prescriptions ‘fail,’ according to 20-year study by Cardiff University in Wales.

AmoxicillinAntibiotics and Infectious diseasesPharmaceuticalResearchTrimethoprimUK

Novo Nordisk establishes new obesity research unit in Seattle

Novo Nordisk establishes new obesity research unit in Seattle

26-09-2014

Danish diabetes care giant Novo Nordisk yesterday announced that the company will establish a new obesity…

ManagementMetabolicsNovo NordiskPharmaceuticalResearchSaxendaUSA

Top 100 US drug pricing average jumps seven-fold to $9,400 in 2014

Top 100 US drug pricing average jumps seven-fold to $9,400 in 2014

26-09-2014

The median price of the top 100 drugs has skyrocketed from $1,260 in 2010 to $9,400 in 2014, representing…

PharmaceuticalPharmacologyPricingUnited StatesUSA

Boehringer’s Spiriva Respimat OKed by FDA for maintenance treatment of COPD

Boehringer’s Spiriva Respimat OKed by FDA for maintenance treatment of COPD

25-09-2014

German family-owned pharma major Boehringer Ingelheim Pharmaceuticals has received US Food and Drug Administration…

Boehringer IngelheimPharmaceuticalRegulationRespiratory and PulmonarySpirivaUSA

AbbVie's Humira gains added indication from US FDA

AbbVie's Humira gains added indication from US FDA

25-09-2014

The US Food and Drug Administration has approved US drugmaker AbbVie’s Humira (adalimumab) for reducing…

AbbVieGastro-intestinalsHumiraInflammatory diseasesPharmaceuticalRegulationUSA

FDA warning letters rise 78% over six years with increase expected in 2015

FDA warning letters rise 78% over six years with increase expected in 2015

25-09-2014

The number of warning letters sent by the US Food and Drug Administration increased substantially by…

PharmaceuticalRegulationUSA

Helsinn to present anamorelin Phase III data at European Society for Medical Oncology Congress

Helsinn to present anamorelin Phase III data at European Society for Medical Oncology Congress

25-09-2014

Family-run Swiss oncology specialist Helsinn is to present Phase III data on anamorelin at the 38th European…

anamorelinHelsinnOncologyPharmaceuticalResearchSwitzerland

21 to 45 of 7041 results

Back to top